Corient Private Wealth LLC Has $229.03 Million Holdings in Danaher Corporation $DHR

Corient Private Wealth LLC decreased its position in shares of Danaher Corporation (NYSE:DHR) by 0.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 999,144 shares of the conglomerate’s stock after selling 6,574 shares during the quarter. Corient Private Wealth LLC’s holdings in Danaher were worth $229,025,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Elevated Capital Advisors LLC acquired a new position in Danaher during the fourth quarter worth $26,000. Hilton Head Capital Partners LLC acquired a new position in shares of Danaher during the fourth quarter valued at about $27,000. Clal Insurance Enterprises Holdings Ltd grew its holdings in shares of Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after buying an additional 53 shares during the last quarter. JPL Wealth Management LLC bought a new stake in shares of Danaher during the third quarter worth about $25,000. Finally, WFA of San Diego LLC acquired a new stake in shares of Danaher in the 2nd quarter worth about $26,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of Danaher stock opened at $177.74 on Friday. The business’s fifty day simple moving average is $179.62 and its 200 day simple moving average is $203.07. The firm has a market capitalization of $125.80 billion, a P/E ratio of 34.38, a price-to-earnings-growth ratio of 2.26 and a beta of 0.81. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the prior year, the company earned $1.88 EPS. The business’s revenue for the quarter was up 3.7% on a year-over-year basis. As a group, analysts anticipate that Danaher Corporation will post 8.45 EPS for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s dividend payout ratio is presently 30.95%.

Analysts Set New Price Targets

DHR has been the topic of several recent research reports. Argus dropped their price target on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. Citigroup assumed coverage on Danaher in a report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective for the company. HSBC lowered their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. The Goldman Sachs Group cut their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Monday, April 13th. Finally, UBS Group decreased their price target on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.